Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Diagnostics » HME-8950118
  • Global Blood Group Typing Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: January 2018 | Report Code: HME-8950118

* For discount/customization and buying a particular chapter click here or write to us at sales@occamsresearch.com

Blood group typing includes the different techniques and methods which are used to identify the blood group. The global blood group typing market is expected to grow  at a CAGR of 9.8% during forecast period 2016-2023. Rising number of blood donations and awareness for the blood group  donations driving the market. According to world health organization (WHO), in 2017, approx. 112.5 million blood donations collected globally. There is rise in demand for blood components (plasma components, plasma derivatives, cellular components) and blood transfusion, specifically in middle and low income countries due to lower healthcare infrastructure. Transfusion saves lives and improves health, but many patients who require transfusion do not have timely access to safe blood. Providing safe and adequate blood should be an integral part of every country’s national health care policy and infrastructure. As per WHO, blood donation on the basis of sample of 1000 people in different countries is about 32% in high income countries, 14.9% in upper middle income countries, and 7.8% in lower middle income countries and 4.6% in lower income countries as per the . To encourage people for blood donation WHO has launched a campaign in 2015, – “thank you for saving my life”.

Transfusion of blood products is driving the global blood group typing market. It supports in surgical and complex medical procedures. Transfusion plays an essential role in child care and maternal care. Blood transfusion is defined as the process of receiving blood products into one’s circulation intravenously. This is usually done as a lifesaving maneuver to replace blood cells or blood component which are lost through severe bleeding, during surgery when severe blood loss occurs or to increase the blood count in an anemic patient. A blood transfusion involves whole blood, red blood cells, white blood cells, plasma and platelets. According to world health organization about 65% of blood transfusion is provided to children below 5 years in low income countries due to the lack of proper nourishment to the children’s in low income . Whereas in high income countries people over age of 65 years are the most frequently transfused patient, owing to the rise in standard of living due to high income, it increases the life expectancy of people. This, shows rising incidence of blood transfusion is likely to drive the market for blood group typing for the forecast period.

Source: OBRC Analysis

The methodology for research used in blood group typing market is through both primary and secondary research. After estimating total market size, the data was split into respective segments within. The overall market valuation was verified through primary research, by consulting industry experts and association members. The base year for estimating market is 2015 and forecast period is 2016-2023. The currency denomination maintained throughout the report is dollar ($) million.

The report on global blood group typing market is segmented on basis of product and services type, application, and end-user.

On the basis of product and services market segment is classified as:

  • Consumables
  • Instruments
  • Services





On the basis of techniques market segment is classified into:

  • PCR-Based and Microarray Techniques
  • Assay-Based Techniques
  • Massively Parallel Sequencing
  • Other Techniques






On the basis of test type segment market is classified as:

  • Antibody Screening
  • HLA Typing
  • ABO Blood Tests
  • Cross-Matching Tests
  • Antigen Typing







On the basis of end user segment market is classified as:

  • Hospitals
  • Clinical Laboratories
  • Blood Banks
  • Other End Users






Market report has been geographically segmented into:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World






Geographically, North America is expected to dominate the market. Followed by Europe and Asia-pacific. Factors such as, reimbursement availability for several surgeries, increasing incidence of chronic diseases, and the high rate aging population in this region are driving the market growth. In addition, APAC is expected to be fasted growing region, majorly centered on China, India and Japan due to their large population in these area.

On the basis of product & service, consumables market segment is further classified into antisera reagents, red blood cells reagents, anti-human globulin reagents and blood bank saline. The consumables segment is likely to grow with a CAGR for the forecast period. Increasing rate of blood donation and major transplantations or surgical procedures are the key factors contributing to the growth of segment. On the basis of technique, microarray and PCR-based techniques segment is likely to grow with the highest CAGR for the forecast period. Rising incidence of chronic diseases and R&D activities for molecular based of blood and antibody and antigen interactions are key factor contributing for the market growth.  On the basis of test type, antibody screening is likely to grow with the highest CAGR for the forecast period. Rising demand for early diagnosis of chronic diseases is driving the market. On the basis of end user, hospitals end-user is likely to grow with a high CAGR for the forecast period. Increasing awareness for blood donations and its importance, rising requirement of blood in surgeries, and growing number of blood donations is driving the market.

The major market players of the global blood group typing market are:                          

  • Bio-Rad laboratories, Inc. (U.S.)
  • Ortho clinical diagnostics, Inc. (U.S.)
  • Bag healthcare GMBH (Germany)
  • Day medical SA (Switzerland)
  • Merck KGAA(GERMANY)
  • And others








These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, new product launch is the key strategy adopted by the companies. For instance, Bio-Rad Laboratories Inc., which is one of the leading manufacturer of clinical diagnostic products, and life sciences with approval of U.S. Food and Drug Administration (FDA) approval, In October 2016, launched its new product IH-1000 blood instrument. Also, InJuly, 2017 Bio-Rad Laboratories and VISIA Imaging entered into partnership. Jointly there two companies enhanced there business capabilities by providing new techniques for the evaluation of autoimmune diseases.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in blood group typing market.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023
  • Report includes detailed analysis of different segments such as product and services type, application of blood group typing market.
  • Identify and understand the strength, opportunities, challenges and threat of the blood group typing market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, and competitive landscape analysis of major players of blood group typing market.
  • Detailed analysis of various the regulatory policies which are affecting the global blood group typing market.
  • Current and future market trends to justify the forthcoming attractive markets within the blood group typing market.








How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on blood group typing market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the blood group typing market, with giving extensive SCOT analysis of key companies.

Key findings of the global blood group typing market.

  • Product launch & partnership is the key strategy adopted by market players
  • North America is expected to dominate the market and increasing incidence of chronic diseases
  • APAC is the fastest growing region for this market.
  • Consumables segment is leading due to increasing rate of blood donation and major transplantations or surgical procedures. 
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL BLOOD GROUP TYPING MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. TOTAL MARKET ANALYSIS
2.4.1. TOP 5 FINDINGS
2.4.2. TOP 5 OPPORTUNITY MARKETS
2.4.3. TOP 5 COMPANIES
2.4.4. TOP 3 COMPETITIVE STRATEGIES
2.5. ESTIMATION ANALYSIS
2.6. STRATEGIC ANALYSIS
2.6.1. INVESTMENT VS. ADOPTION MODEL
2.6.2. 360-DEGREE INDUSTRY ANALYSIS
2.6.3. PORTERS 5 FORCE MODEL
2.6.4. SEE-SAW ANALYSIS
2.6.5. ROI ANALYSIS
2.6.6. GAP ANALYSIS
2.6.7. PATENT ANALYSIS
2.6.8. PRICING ANALYSIS
2.6.9. PIPELINE ANALYSIS
2.6.10. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.7. COMPETITIVE ANALYSIS
2.7.1. KEY STRATEGIES & ANALYSIS
2.7.2. MARKET SHARE ANALYSIS AND TOP MARKET ANALYSIS
2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASED NUMBER OF BLOOD DONATIONS
3.1.2. GROWING NUMBER OF ACCIDENTS, EMERGENCIES, AND TRAUMA CASES REQUIRED BLOOD TRANSFUSIONS 
3.1.3. INCREASED USAGE IN FORENSIC SCIENCE
3.1.4. GROWING DEMAND OF BLOOD GROUP TYPING IN PRENATAL TESTING
3.2. MARKET RESTRAINTS
3.2.1. STRINGENT, REGULATORY PROCESS
3.3. MARKET OPPORTUNITIES
3.3.1. EMERGING ECONOMICS 
3.3.2. BLOOD GROUP TYPING WITH MOLECULAR DIAGNOSTICS
3.4. MARKET CHALLENGES
3.4.1. LACK OF SKILLED PROFESSIONALS 
 
4. MARKET SEGMENTATION
4.1. GLOBAL  BLOOD GROUP TYPING   MARKET BY PRODUCT AND SERVICES
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL CONSUMABLES MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL INSTRUMENTS MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SERVICES MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL  BLOOD GROUP TYPING  MARKET BY TECHNIQUES 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL PCR- BASED AND MICROARRAY TECHNIQUES MARKET
4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.4. KEY CONCLUSIONS
4.2.5.2. GLOBAL   ASSAY- BASED TECHNIQUES MARKET
4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.4. KEY CONCLUSIONS
4.2.5.3. GLOBAL  MASSIVELY PARALLEL SEQUENCING MARKET
4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.4. KEY CONCLUSIONS
4.2.5.4. GLOBAL  OTHER TECHNIQUES MARKET
4.2.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.2.5.4.4. KEY CONCLUSIONS
4.3. GLOBAL  BLOOD GROUP TYPING  MARKET BY  TEST TYPE 
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL ANTIBODY SCREENING MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL  HLA TYPING MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.2.4. KEY CONCLUSIONS
4.3.5.3. GLOBAL   ABO BLOOD TESTS MARKET
4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.3.4. KEY CONCLUSIONS
4.3.5.4. GLOBAL CROSS MATCHING TESTS MARKET
4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.4.4. KEY CONCLUSIONS
4.3.5.5. GLOBAL ANTIGEN TYPING MARKET
4.3.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.3. KEY PLAYERS & KEY PRODUCTS
4.3.5.5.4. KEY CONCLUSIONS
4.4. GLOBAL  BLOOD GROUP TYPING  MARKET BY  END USER 
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION
4.4.5.1. GLOBAL  HOSPITALS MARKET
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL   CLINICAL LABORATORIES MARKET
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL BLOOD BANKS MARKET
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.3.4. KEY CONCLUSIONS
4.4.5.4. GLOBAL OTHER END USERS MARKET
4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS
4.4.5.4.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL  BLOOD GROUP TYPING  MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. RUSSIA
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. BIO-RAD LABORATORIES, INC. (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
7.2. GRIFOLS, S.A. (SPAIN)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
7.3. IMMUCOR, INC. (U.S.)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
7.4. ORTHO CLINICAL DIAGNOSTICS, INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
7.5. QUOTIENT, LTD. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
7.6. NOVACYT GROUP (FRANCE)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
7.7. BAG HEALTHCARE GMBH (GERMANY)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
7.8. RAPID LABS (U.K.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
7.9. DAY MEDICAL SA (SWITZERLAND)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
7.10. DIAGAST (FRANCE)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
7.11. AXO SCIENCE (FRANCE)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
7.12. AGENA BIOSCIENCE, INC (U.S.)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. MERCK KGAA(GERMANY)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. BECKMAN COULTER(U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. DAY MEDICAL SA (SWITZERLAND)
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
1. GLOBAL  BLOOD GROUP TYPING  MARKET BY PRODUCT  2014-2023 ($ MILLION)
2. GLOBAL CONSUMABLES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL SERVICES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL  BLOOD GROUP TYPING  MARKET BY TECHNIQUE 2014-2023 ($ MILLION)
6. GLOBAL PCR-BASED AND MICROARRAY TECHNIQUES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL ASSAY-BASED TECHNIQUES DIAGNOSTIC IMAGING DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL MASSIVELY PARALLEL SEQUENCING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL  BLOOD GROUP TYPING  MARKET BY  TEST TYPE 2014-2023 ($ MILLION)
12. GLOBAL ANTIBODY SCREENING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL HLA TYPING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL  ABO BLOOD TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL CROSS MATCHING TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL ANTIGEN TYPING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL  BLOOD GROUP TYPING  MARKET BY  END USER 2014-2023 ($ MILLION)
18. GLOBAL BLOOD BANKS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
19. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL  CLINICAL LABORITES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. GLOBAL OTHER END USERS  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
22. NORTH AMERICA  BLOOD GROUP TYPING  MARKET 2014-2023 ($ MILLION)
23. EUROPE  BLOOD GROUP TYPING  MARKET  2014-2023 ($ MILLION)
24. ASIA PACIFIC  BLOOD GROUP TYPING  MARKET 2014-2023 ($ MILLION)
25. REST OF THE  BLOOD GROUP TYPING  MARKET  2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL CONSUMABLES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
2. GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL SERVICES  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL PCR-BASED AND MICROARRAY TECHNIQUES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
6. GLOBAL ASSAY-BASED TECHNIQUES DIAGNOSTIC IMAGING DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL MASSIVELY PARALLEL SEQUENCING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL OTHER TECHNIQUES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL ANTIBODY SCREENING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL HLA TYPING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL  ABO BLOOD TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL CROSS MATCHING TESTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL ANTIGEN TYPING MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL BLOOD BANKS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL  CLINICAL LABORITES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL OTHER END USERS  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. NORTH AMERICA  BLOOD GROUP TYPING  MARKET 2014-2023 ($ MILLION)
19. EUROPE  BLOOD GROUP TYPING  MARKET  2014-2023 ($ MILLION)
20. ASIA PACIFIC  BLOOD GROUP TYPING  MARKET 2014-2023 ($ MILLION)
21. REST OF THE  BLOOD GROUP TYPING  MARKET  2014-2023 ($ MILLION)
22. UNITED STATES (U.S.)  BLOOD GROUP TYPING  MARKET 2014-2023 ($ MILLION)
23. CANADA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
24. UNITED KINGDOM (UK)  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
25. FRANCE  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
26. GERMANY  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
27. RUSSIA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
28. ROE  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
29. INDIA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
30. CHINA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
31. JAPAN  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
32. AUSTRALIA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
33. ROAPAC  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
34. LATIN AMERICA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)
35. MENA  BLOOD GROUP TYPING  MARKET 2014-2023  ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: info@occamsresearch.com

 

 

Go To Top
viewthroughconversion